Basilea Pharmaceutica AG
XBER:PK5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Basilea Pharmaceutica AG
XBER:PK5
|
CH |
|
P
|
Pampa Metals Corp
CNSX:PM
|
CA |
|
Reebonz Holding Ltd
OTC:RBZHF
|
SG |
|
A
|
Allegra Orthopaedics Ltd
ASX:AMT
|
AU |
|
Q
|
Quimbaya Gold Inc
OTC:QIMGF
|
CA |
|
Kunlun Energy Company Ltd
F:CTJ1
|
HK |
|
Elixinol Wellness Ltd
OTC:ELLXF
|
AU |
|
A
|
Aevis Victoria SA
F:G5LN
|
CH |
|
S
|
Smart Metering Systems PLC
F:SMC
|
UK |
|
S
|
Sangsangin Industry Co Ltd
KOSDAQ:101000
|
KR |
|
Sekur Private Data Ltd
F:GDT0
|
CA |
|
M
|
Monex Group Inc
F:NNL
|
JP |
|
Hometrust Bancshares Inc
NYSE:HTB
|
US |
|
A
|
Anhui Expressway Co Ltd
OTC:AUHEF
|
CN |
|
Sodexo SA
F:SJ7
|
FR |
|
T
|
Tsubota Laboratory Inc
TSE:4890
|
JP |
|
Gaming Corps AB
F:5WF
|
SE |
|
O
|
Origo Partners PLC
XBER:LTL
|
IM |
|
A
|
Aferian PLC
OTC:AOECF
|
UK |
Wall St Price Targets
PK5 Price Targets Summary
Basilea Pharmaceutica AG
According to Wall Street analysts, the average 1-year price target for PK5 is 50.7 EUR with a low forecast of 35.74 EUR and a high forecast of 63.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PK5's stock price target?
Price Target
50.7
EUR
According to Wall Street analysts, the average 1-year price target for PK5 is 50.7 EUR with a low forecast of 35.74 EUR and a high forecast of 63.69 EUR.
What is the Revenue forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 2%.
What is the Gross Profit forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 2%.
What is the Operating Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
13%
The compound annual growth rate for Operating Income over the next 5 years is 13%.
What is the Pre-Tax Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
-22%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.
What is the Net Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
17%
The compound annual growth rate for Net Income over the next 5 years is 17%.
